These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 30503548)
1. Diclazuril nonlinear mixed-effects pharmacokinetic modelling of plasma concentrations after oral administration to adult horses every 3-4 days. Hunyadi L; Papich MG; Pusterla N Vet J; 2018 Dec; 242():74-76. PubMed ID: 30503548 [TBL] [Abstract][Full Text] [Related]
2. Diclazuril in the horse: its identification and detection and preliminary pharmacokinetics. Dirikolu L; Lehner F; Nattrass C; Bentz BG; Woods WE; Carter WG; Karpiesiuk W; Jacobs J; Boyles J; Harkins JD; Granstrom DE; Tobin T J Vet Pharmacol Ther; 1999 Dec; 22(6):374-9. PubMed ID: 10651466 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of a low dose and FDA-labeled dose of diclazuril administered orally as a pelleted topdressing in adult horses. Hunyadi L; Papich MG; Pusterla N J Vet Pharmacol Ther; 2015 Jun; 38(3):243-8. PubMed ID: 25329774 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of a FDA-labeled dose of diclazuril administered orally once weekly to adult horses. Pusterla N; Vaala W; Bain FT; Chappell DE; Craig B; Schneider C; Barnett DC; Gaughan E; Papich MG J Equine Vet Sci; 2023 Jan; 120():104183. PubMed ID: 36470515 [TBL] [Abstract][Full Text] [Related]
5. New therapeutic approaches for equine protozoal myeloencephalitis: pharmacokinetics of diclazuril sodium salts in horses. Dirikolu L; Karpiesiuk W; Lehner AF; Hughes C; Woods WE; Harkins JD; Boyles J; Atkinson A; Granstrom DE; Tobin T Vet Ther; 2006; 7(1):52-63, 72. PubMed ID: 16598684 [TBL] [Abstract][Full Text] [Related]
6. Daily feeding of diclazuril top dress pellets in foals reduces seroconversion to Sarcocystis neurona. Pusterla N; Packham A; Mackie S; Kass PH; Hunyadi L; Conrad PA Vet J; 2015 Nov; 206(2):236-8. PubMed ID: 26346260 [TBL] [Abstract][Full Text] [Related]
7. Investigation of the Bi-Weekly Administration of Diclazuril on the Antibody Kinetics to Sarcocystis Neurona in Healthy Horses. Pusterla N; James K; Bain F; Barnett DC; Chappell D; Gaughan E; Craig B; Schneider C; Vaala W; Papich M J Equine Vet Sci; 2021 Sep; 104():103713. PubMed ID: 34416990 [TBL] [Abstract][Full Text] [Related]
8. Determination of the activity of diclazuril against Sarcocystis neurona and Sarcocystis falcatula in cell cultures. Lindsay DS; Dubey JP J Parasitol; 2000 Feb; 86(1):164-6. PubMed ID: 10701584 [TBL] [Abstract][Full Text] [Related]
10. Effect of intermittent oral administration of ponazuril on experimental Sarcocystis neurona infection of horses. Mackay RJ; Tanhauser ST; Gillis KD; Mayhew IG; Kennedy TJ Am J Vet Res; 2008 Mar; 69(3):396-402. PubMed ID: 18312139 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing. Furr M; Kennedy T Vet Ther; 2000; 1(2):125-32. PubMed ID: 19757559 [TBL] [Abstract][Full Text] [Related]
12. Toltrazuril sulfone sodium salt: synthesis, analytical detection, and pharmacokinetics in the horse. Dirikolu L; Karpiesiuk W; Lehner AF; Tobin T J Vet Pharmacol Ther; 2012 Jun; 35(3):265-74. PubMed ID: 21679197 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and detection of toltrazuril sulfone and its pharmacokinetics in horses following administration in dimethylsulfoxide. Dirikolu L; Karpiesiuk W; Lehner AF; Hughes C; Granstrom DE; Tobin T J Vet Pharmacol Ther; 2009 Aug; 32(4):368-78. PubMed ID: 19614842 [TBL] [Abstract][Full Text] [Related]
14. Plasma disposition of toltrazuril and its metabolites, toltrazuril sulfoxide and toltrazuril sulfone, in rabbits after oral administration. Kim MS; Lim JH; Hwang YH; Park BK; Song IB; Yun HI Vet Parasitol; 2010 Apr; 169(1-2):51-6. PubMed ID: 20083354 [TBL] [Abstract][Full Text] [Related]
15. Influence of mycotoxin binders on the oral bioavailability of tylosin, doxycycline, diclazuril, and salinomycin in fed broiler chickens. De Mil T; Devreese M; Maes A; De Saeger S; De Backer P; Croubels S Poult Sci; 2017 Jul; 96(7):2137-2144. PubMed ID: 28160001 [TBL] [Abstract][Full Text] [Related]
16. Dose-response effects of diclazuril against pathogenic species of ovine coccidia and the development of protective immunity. Taylor MA; Marshall RN; Marshall JA; Catchpole J; Bartram D Vet Parasitol; 2011 May; 178(1-2):48-57. PubMed ID: 21232870 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of toltrazuril and its metabolites in pregnant and nonpregnant ewes and determination of their concentrations in milk, allantoic fluid, and newborn plasma. Al-Qadri RF; Abu-Basha EA; Ababneh MM; Bani Ismail Z; Idkaidek NM J Vet Pharmacol Ther; 2020 Jul; 43(4):339-346. PubMed ID: 32067240 [TBL] [Abstract][Full Text] [Related]
18. Detection, quantifications, and pharmacokinetics of ponazuril in healthy swine. Zou M; Guo G; Zhao Y; Zhang Q J Vet Pharmacol Ther; 2014 Dec; 37(6):598-602. PubMed ID: 24731142 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and improved bioavailability of toltrazuril after oral administration to rabbits. Hu L; Liu C; Shang C; Yang X; Yang J J Vet Pharmacol Ther; 2010 Oct; 33(5):503-6. PubMed ID: 20860101 [No Abstract] [Full Text] [Related]
20. Pharmacokinetics, Activity, and Residue Elimination of Zhang M; Qiu J; Shu X; Tang X; Sha X; Wu L; Fan J; Zeng D; He R; Zhang W; Zeng Z; Liu R; He L J Agric Food Chem; 2020 Aug; 68(33):8987-8995. PubMed ID: 32692165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]